152 related articles for article (PubMed ID: 27060276)
1. Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.
Zhou YF; Yu Y; Sun J; Tao MT; Zhou WJ; Li X; Liao XP; Liu YH
Anaerobe; 2016 Jun; 39():150-7. PubMed ID: 27060276
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens.
Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH
Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809
[TBL] [Abstract][Full Text] [Related]
3. Establishment of valnemulin susceptibility breakpoint against Clostridium perfringens in rabbits.
Tao MT; Zhou YF; Sun J; Liu YH; Liao XP
Anaerobe; 2017 Dec; 48():118-120. PubMed ID: 28801120
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z
J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333
[TBL] [Abstract][Full Text] [Related]
6. Integration of pharmacokinetic and pharmacodynamic indices of valnemulin in broiler chickens after a single intravenous and intramuscular administration.
Zhao DH; Zhou YF; Yu Y; Shi W; Yang X; Xiao X; Deng H; Qiao GG; Fang BH; Liu YH
Vet J; 2014 Jul; 201(1):109-15. PubMed ID: 24906499
[TBL] [Abstract][Full Text] [Related]
7. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.
Yan L; Xie S; Chen D; Pan Y; Tao Y; Qu W; Liu Z; Yuan Z; Huang L
Sci Rep; 2017 Jun; 7(1):4064. PubMed ID: 28642571
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of valnemulin in Muscovy ducks (Cairina moschata).
Sun J; Yuan L; Zhu L; He L; Luo X; Wang R; Liu Y
Br Poult Sci; 2012; 53(3):374-8. PubMed ID: 22978594
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks.
Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH
BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of moxifloxacin against anaerobes studied in an in vitro pharmacokinetic model.
Noel AR; Bowker KE; Macgowan AP
Antimicrob Agents Chemother; 2005 Oct; 49(10):4234-9. PubMed ID: 16189103
[TBL] [Abstract][Full Text] [Related]
12.
Zhang W; Lu Y; Ma M; Yang J; Huang H; Peng X; Zeng Z; Zeng D
Front Vet Sci; 2024; 11():1362292. PubMed ID: 38756506
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
Lepak AJ; Marchillo K; Craig WA; Andes DR
Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model.
Xiao X; Sun J; Yang T; Fang X; Wu D; Xiong YQ; Cheng J; Chen Y; Shi W; Liu YH
Antimicrob Agents Chemother; 2015 Jul; 59(7):3754-60. PubMed ID: 25845865
[TBL] [Abstract][Full Text] [Related]
15. Dosage assessment of valnemulin in pigs based on population pharmacokinetic and Monte Carlo simulation.
Yuan LG; Tang YZ; Zhang YX; Sun J; Luo XY; Zhu LX; Zhang Z; Wang R; Liu YH
J Vet Pharmacol Ther; 2015 Aug; 38(4):400-9. PubMed ID: 25604162
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioavailability of valnemulin in broiler chickens.
Wang R; Yuan LG; He LM; Zhu LX; Luo XY; Zhang CY; Yu JJ; Fang BH; Liu YH
J Vet Pharmacol Ther; 2011 Jun; 34(3):247-51. PubMed ID: 21492189
[TBL] [Abstract][Full Text] [Related]
17. The effects of subminimal inhibitory concentrations of beta-lactam antibiotics against Clostridium perfringens.
Kondo F; Kuroki H
Microbios; 2001; 105(412):163-74. PubMed ID: 11414501
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs.
Yohannes S; Awji EG; Lee SJ; Park SC
Xenobiotica; 2015 Mar; 45(3):264-9. PubMed ID: 25470431
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
